Can a Two-Day diet change help fight brain cancer?
NCT ID NCT07553520
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study aimed to see if a diet low in two specific nutrients (cysteine and methionine) could affect metabolism in patients with recurrent gliomas. Up to 30 participants were to be randomly assigned to either a normal diet or the special diet for 2, 4, or 7 days before standard treatment. Researchers planned to measure changes in blood, urine, and tumor samples to understand how the diet impacts cancer cells. However, the study was withdrawn before enrolling any participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cysteine/methionine deprivation (CMD) diet
- What this could lead to
- If successful, this could point toward a dietary approach to help manage brain tumors by altering cancer cell metabolism.
- What could go wrong
- This is a very early pilot study with no participants enrolled, so results are uncertain. The diet is short-term and may not affect tumor growth or survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, North Carolina, 27514, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a parasite drug fight childhood brain tumors?
- Can mapping the Blood-Brain barrier in brain tumors unlock new clues?
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- Brain cancer vaccine targets survivin protein to boost immune attack
- AI reads brain scans to predict tumor survival before surgery
- Can a drug make radiation work better against aggressive brain tumors?